These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Optimal temperature for whole-body hypothermia in the newborn: an in vitro study using foreskin mitochondrial oxygen consumption. Al Zaabi A; Rahmani AY; Souid A J Neonatal Perinatal Med; 2014 Jan; 7(3):179-83. PubMed ID: 25322994 [TBL] [Abstract][Full Text] [Related]
4. Effect of Zoledronic Acid Application on Different Graft Materials in Calvarial Bone Defect Models. An Experimental Analysis. Koparal M; Gülsün B; Deveci E; Agacayak KS; Hamidi A Anal Quant Cytopathol Histpathol; 2016 Apr; 38(2):117-25. PubMed ID: 27386633 [TBL] [Abstract][Full Text] [Related]
5. Dactinomycin impairs cellular respiration and reduces accompanying ATP formation. Tao Z; Ahmad SS; Penefsky HS; Goodisman J; Souid AK Mol Pharm; 2006; 3(6):762-72. PubMed ID: 17140264 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Oxygen Consumption by the Foreskin and its Fibroblast-rich Culture. Al-Jasmi F; Pramathan T; Swid A; Sahari B; Penefsky HS; Souid AK Sultan Qaboos Univ Med J; 2013 Aug; 13(3):411-6. PubMed ID: 23984027 [TBL] [Abstract][Full Text] [Related]
7. Effects of resveratrol on the rat brain respiratory chain. Zini R; Morin C; Bertelli A; Bertelli AA; Tillement JP Drugs Exp Clin Res; 1999; 25(2-3):87-97. PubMed ID: 10370869 [TBL] [Abstract][Full Text] [Related]
8. Cellular Respiration in Thymic Fragments from Mice. Alshamsi M; Hassane M; Almarzooqi F; Souid AK Front Biosci (Landmark Ed); 2022 Jul; 27(8):230. PubMed ID: 36042174 [TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid increases the circulating soluble RANKL level in mice, with a further increase in lymphocyte-derived soluble RANKL in zoledronic acid- and glucocorticoid-treated mice stimulated with bacterial lipopolysaccharide. Abe T; Sato T; Kokabu S; Hori N; Shimamura Y; Sato T; Yoda T Cytokine; 2016 Jul; 83():1-7. PubMed ID: 26999703 [TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacology of zoledronic acid. Green JR Semin Oncol; 2002 Dec; 29(6 Suppl 21):3-11. PubMed ID: 12584689 [TBL] [Abstract][Full Text] [Related]
11. Doses effects of zoledronic acid on mineral apatite and collagen quality of newly-formed bone in the rat's calvaria defect. Olejnik C; Falgayrac G; During A; Cortet B; Penel G Bone; 2016 Aug; 89():32-39. PubMed ID: 27168397 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. Daubiné F; Le Gall C; Gasser J; Green J; Clézardin P J Natl Cancer Inst; 2007 Feb; 99(4):322-30. PubMed ID: 17312309 [TBL] [Abstract][Full Text] [Related]
13. Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer. Montague R; Hart CA; George NJ; Ramani VA; Brown MD; Clarke NW Eur Urol; 2004 Sep; 46(3):389-401; discussion 401-2. PubMed ID: 15306113 [TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival. Croucher PI; De Hendrik R; Perry MJ; Hijzen A; Shipman CM; Lippitt J; Green J; Van Marck E; Van Camp B; Vanderkerken K J Bone Miner Res; 2003 Mar; 18(3):482-92. PubMed ID: 12619933 [TBL] [Abstract][Full Text] [Related]
16. Cyanide-resistant respiration in Taenia crassiceps metacestode (cysticerci) is explained by the H2O2-producing side-reaction of respiratory complex I with O2. del Arenal IP; Rubio ME; Ramírez J; Rendón JL; Escamilla JE Parasitol Int; 2005 Sep; 54(3):185-93. PubMed ID: 15958286 [TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. Little DG; Peat RA; Mcevoy A; Williams PR; Smith EJ; Baldock PA J Bone Miner Res; 2003 Nov; 18(11):2016-22. PubMed ID: 14606515 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice. Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202 [TBL] [Abstract][Full Text] [Related]
19. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel. Jagdev SP; Coleman RE; Shipman CM; Rostami-H A; Croucher PI Br J Cancer; 2001 Apr; 84(8):1126-34. PubMed ID: 11308265 [TBL] [Abstract][Full Text] [Related]